GNRH1 and neoplasm: Luteinizing hormone-releasing hormone (LHRH) peptide-modified PAMAM dendrimers effectively delivered anti-MCL-1 siRNA, inducing apoptosis and tumor suppression in LNCaP cells, thus offering a targeted strategy for LHRH-overexpressing tumors [235].